For example, Venkat and colleagues have demonstrated that the intravenous injection of EVs derived from prominin-1+ human umbilical cord blood cells into mice with type 2 diabetes mellitus that were subjected to stroke significantly improved neurocognitive outcomes and reduced cardiac and hepatic dysfunction. Here, PROM1 is linked to type 2 diabetes mellitus.